Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
-4.21%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$16.9B
AUM Growth
-$2.13B
(-11%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
39.23%
Holding
1,372
New
74
Increased
459
Reduced
680
Closed
155
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$126M |
| 2 |
NVIDIA
NVDA
|
+$75.8M |
| 3 |
Synaptics
SYNA
|
+$33.9M |
| 4 |
Microchip Technology
MCHP
|
+$29.7M |
| 5 |
ON Semiconductor
ON
|
+$23.8M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$185M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$169M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$154M |
| 4 |
Apple
AAPL
|
+$136M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$120M |
Sector Composition
| 1 | Technology | 36.16% |
| 2 | Financials | 15.02% |
| 3 | Energy | 6.15% |
| 4 | Healthcare | 5.33% |
| 5 | Consumer Discretionary | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Alnylam Pharmaceuticals
ALNY
$61.1B
| $6.05M | 0.04% |
37,035
+5,090
| +16% | +$831K |
|
327
Twist Bioscience
TWST
$1.53B
| $6.03M | 0.04% |
122,098
+58,645
| +92% | +$2.9M |
|
328
Emergent Biosolutions
EBS
$434M
| $6.02M | 0.04% |
146,628
+14,963
| +11% | +$614K |
|
|
REGI
329
DELISTED
Renewable Energy Group, Inc.
REGI
| $6M | 0.04% |
98,930
-107,916
| -52% | -$6.54M |
|
330
Akamai
AKAM
$11B
| $6M | 0.04% |
50,224
-7,669
| -13% | -$916K |
|
|
BPMC
331
DELISTED
Blueprint Medicines
BPMC
| $5.98M | 0.04% |
93,635
+39,214
| +72% | +$2.5M |
|
332
Karyopharm Therapeutics
KPTI
$55.9M
| $5.96M | 0.04% |
53,929
+28,558
| +113% | +$3.16M |
|
333
Exact Sciences
EXAS
$10.2B
| $5.96M | 0.04% |
85,214
+18,713
| +28% | +$1.31M |
|
334
PTC Therapeutics
PTCT
$4.85B
| $5.95M | 0.04% |
159,390
+17,237
| +12% | +$643K |
|
335
Dynavax Technologies
DVAX
$1.1B
| $5.95M | 0.04% |
548,421
+152,838
| +39% | +$1.66M |
|
336
Ultragenyx Pharmaceutical
RARE
$2.92B
| $5.94M | 0.04% |
81,737
+14,046
| +21% | +$1.02M |
|
337
Everest Group
EG
$14.7B
| $5.9M | 0.03% |
19,559
-950
| -5% | -$286K |
|
338
JD.com
JD
$47.7B
| $5.87M | 0.03% |
101,501
+43,497
| +75% | +$2.52M |
|
339
FNB Corp
FNB
$5.89B
| $5.87M | 0.03% |
471,593
+29,459
| +7% | +$367K |
|
340
Baidu
BIDU
$39.5B
| $5.87M | 0.03% |
44,356
+15,356
| +53% | +$2.03M |
|
341
iShares MSCI Mexico ETF
EWW
$1.92B
| $5.85M | 0.03% |
106,492
-35,986
| -25% | -$1.98M |
|
342
Alkermes
ALKS
$4.45B
| $5.82M | 0.03% |
221,044
-23,079
| -9% | -$607K |
|
343
Ares Management
ARES
$40.1B
| $5.81M | 0.03% |
71,472
-3,455
| -5% | -$281K |
|
344
TG Therapeutics
TGTX
$5.1B
| $5.78M | 0.03% |
607,625
+289,391
| +91% | +$2.75M |
|
|
SAGE
345
DELISTED
Sage Therapeutics
SAGE
| $5.78M | 0.03% |
174,548
+35,792
| +26% | +$1.18M |
|
346
Exelixis
EXEL
$10.5B
| $5.78M | 0.03% |
254,747
-61,966
| -20% | -$1.4M |
|
347
Sarepta Therapeutics
SRPT
$1.82B
| $5.77M | 0.03% |
73,893
+7,782
| +12% | +$608K |
|
348
Ironwood Pharmaceuticals
IRWD
$213M
| $5.76M | 0.03% |
458,192
-18,594
| -4% | -$234K |
|
|
SRNE
349
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $5.76M | 0.03% |
2,470,682
+1,620,162
| +190% | +$3.78M |
|
350
Danaher
DHR
$136B
| $5.76M | 0.03% |
22,135
-2,194
| -9% | -$571K |
|